PDI, a Top BioPharmaceutical Contract Sales Organization, Selects Veeva Systems` Multi-tenant SaaS CRM System

PLEASANTON, Calif.--(Business Wire)--
PDI, Inc. (Nasdaq: PDII), a leading provider of sales and marketing support to
U.S. pharmaceutical companies, selected Veeva System`s VBioPharma CRM Primary
Care and Special Care Editions, VMobile, and VInsights - all part of the Veeva
CRM suite of multi-tenant SaaS applications. This marks PDI`s continued
commitment to the technology advances in the world of cloud computing where
business spending on SaaS/Cloud applications is expected to rise 22% this year
to $9.6 billion, according to Gartner [http://blogs.zdnet.com/BTL/?p=17662]. All
of PDI`s managed sales forces across various dedicated sales teams plus its
`pulsing` sales teams will go live with Veeva CRM by the end of 2009 to
completely replace its former sales force automation system.

"With Veeva, we can now extend SaaS benefits to meet biopharma needs. Veeva
allows us to provide life sciences companies with tailored solutions without
delay. This flexibility is critical to our success and why we decided to upgrade
from our current CRM application to a highly flexible SaaS system that could
keep up with the steady ebbs and flows of change our customers encounter in this
industry. We now have the ability to make changes to our SFA system quickly and
with less cost and operate within a hardware agnostic environment," said Jo Ann
Saitta, senior vice president, information technology at PDI.

Veeva`s customizable CRM system for life sciences companies hits right at the
heart of PDI`s value proposition: "flexibility to deploy sales and marketing
resources where they will have the greatest impact, and quickly redeploy,
reconfigure and/or disband as business conditions dictate." PDI has been
utilizing other SaaS technologies for over five years with great success. After
several years scrutinizing other CRM options, PDI signed with Veeva.

According to Veeva`s Executive General Manager & Vice President, Matt Wallach,
"Veeva CRM is a perfect fit for organizations like PDI that need to deploy
various sales teams across the country, at different intervals, in different
sizes, and for different needs."

"To date, feedback from the team has been very positive," concluded Saitta. "The
functionality is on target, the architecture has already allowed us to deploy
multiple hardware types and make quick system changes to meet our needs. And,
the field is very positive about the mobility feature for its incredible
efficiencies. Our new SFA is not about a computer or a system; rather, it`s
about enabling the sales force to be efficient, effective, and exceptional!"

About Veeva CRM

The Veeva CRM suite of applications, comprised of VBioPharma, VMobile, and
VInsights, is the life sciences industry`s top multi-tenant SaaS-based CRM
solution. As the foundation, VBioPharma offers multiple editions in one CRM
product to accommodate the unique needs of various life sciences commercial
teams. It is also the only Pharma CRM application to come pre-validated for PDMA
and 21 CFR Part 11 compliance. The complete Veeva CRM suite gives customers the
mobility and reporting solutions needed to drive user adoption and sales
effectiveness.

About Veeva Systems

Veeva Systems is the leader in multi-tenant SaaS-based solutions for the global
life sciences industry. Veeva has dozens of customers ranging from the world`s
largest pharmaceutical companies with thousands of users to emerging biotechs
commercializing their first products. Veeva customers achieve the fastest time
to value through the deployment of fully functional applications that are
flexible, simple to deploy, inexpensive to operate, and provide a superior user
experience. Veeva is a privately-held company headquartered in Pleasanton, CA.
For more information, visit www.veevasystems.com.

Veeva Systems, Inc.
Lisa Barbadora, 610-420-3413
pr@veevasystems.com
or
PDI, Inc.
Amy Lombardi, 201-574-8663
alombardi@pdi-inc.com

Copyright Business Wire 2009